Skip to main content
Premium Trial:

Request an Annual Quote

Agilent and Dharmacon To Combine Microarrays, RNAi

NEW YORK, June 24 - Agilent Technologies and Dharmacon have begun a collaboration to combine Agilent's microarrays and Dharmacon's RNA interference for a measure of gene silencing, the companies said today.

 

Under the agreement, Dharmacon researchers will use RNAi to silence genes and then measure the effects of silencing with Agilent microarrays, and analyze the effect of the RNAi on gene expression with Rosetta Resolver software.

 

This initial collaboration aims at optimizing the companies' methods for use of their technologies together in research.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.